August 5, 2021
Neuropsychotropic Drug Therapy 2019 | CGRP Agents for Migraine Prevention
Neuropsychotropic Drug Therapy 2019
CGRP Agents for Migraine Prevention
Donald Bright, MD
Staff Neurologist, VA Puget Sound Health Care System, Seattle, WA
For psychiatric nurse practitioners, clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Recognize migraine quickly in clinic.
- Discuss the overview of traditional acute and prophylactic treatments.
- Describe CGRP and its role in migraine and as a target for prophylaxis.